Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review

By Marshall Sarah   Fearon Patricia   Dawson Jesse   Quinn Terence J  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 1, 2013-02 ,pp. : 29-42

Informa Healthcare

Access to resources Recommend Favorite

High Prevalence and Undertreatment of Hypercholesterolaemia in Participants in a Public Stroke Prevention Programme in Austria

By Iglseder Bernhard   Moroder Titus   Staffen Wolfgang   Ladurner Gunther  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 709-717

Adis International

Access to resources Recommend Favorite

Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 789-799

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy for the Secondary Prevention of Stroke

By Toyoda Kazunori  

Drugs, Vol. 69, Iss. 6, 2009-01 ,pp. : 633-647

Adis International

Access to resources Recommend Favorite

Clopidogrel for the secondary prevention of stroke

By Diener Hans-Christoph   Ringleb Peter A   Savi Pierre  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 755-764

Informa Healthcare

Access to resources Recommend Favorite